Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Taiwan Sugar Corporation (TSC) is a prominent state-owned enterprise in Taiwan that has successfully transitioned from a traditional sugar producer into a diversified conglomerate with a strong focus on biotechnology. Its Biotechnology Business Division utilizes advanced fermentation and extraction technologies to produce a wide range of health supplements, functional foods, and skincare products. Key offerings include cordyceps sinensis, oyster and clam essences, and collagen-based cosmetics under the "Stanlen" brand. TSC maintains its own research institute and large-scale manufacturing facilities, ensuring high standards of quality and safety. The company is a key player in Taiwan's circular economy and bio-industry, leveraging its agricultural heritage to innovate in the life sciences sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Taiwan Sugar.